Contineum Therapeutics, Inc. — SCHEDULE 13G/A Filings
5 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Contineum Therapeutics, Inc. (CTNM), sorted by most recent first. Each row links to the full filing on EdgarLookup. Contineum Therapeutics, Inc. has filed 5 SCHEDULE 13G/A documents with the SEC since 2023. To view all SEC filings by Contineum Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3
S-8
SC 13G
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001346824-26-000037 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000950170-25-108947 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-072735 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-021230 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-013643 | Feb 14, 2025 | — |